Interventions of Interest
- apitegromab (Scholar Rock Holdings)
For questions please contact Temiwunmi Shobanke, Program Manager, tshobanke@icer.org
View the Key Stakeholder List.
Spinal Muscular Atrophy
An assessment of apitegromab
Public Meeting
August 2025
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Main Review
August 1, 2025
Midwest CEPAC
The Midwest CEPAC’s 2025 public meeting on apitegromab
Public Comment Period
See Full Timeline
01/06/2025 - 01/27/2025
Public Comments on Draft Scoping Document
Related Assessments & Policy Papers.
Spinal Muscular Atrophy
Mar 2019
02/13/2025
Revised Scoping Document
02/24/2025
Research Protocol
Please find the research protocol here:
04/10/2025
Model Analysis Plan
07/17/2025
Evidence Report
08/01/2025
Evidence Presentation
09/02/2025
Public Comments
OpenView
Closed